Clinical Trial Update: Simplification From Protease Inhibitors to Raltegravir [Phase 4]

View source ↗

Summary

Clinical trial update describing a strategy to simplify HIV therapy by switching from protease inhibitors to raltegravir. The study is in Phase 4.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Raltegravir (raltegravir)

Snippet

Sponsor: Hospital Carlos III, Madrid | Conditions: HIV Infections | Phase 4 | Status: UNKNOWN